CN Stock MarketDetailed Quotes

002693 Hainan Shuangcheng Pharmaceuticals

Watchlist
  • 4.50
  • -0.08-1.75%
Not Open Jun 20 15:00 CST
1.88BMarket Cap-29220P/E (TTM)

About Hainan Shuangcheng Pharmaceuticals Company

The company is a high-tech enterprise founded in 2000, characterized by chemically synthesizing polypeptide drugs. It specializes in the production, sales and development of chemically synthesized polypeptide drugs. The company has formed a complete mature technical process system in the synthesis, purification, analysis, quality assurance, activity determination, and formulation process of chemically synthesized polypeptide drugs. The company was listed on the small to medium edition of the Shenzhen Stock Exchange on August 8, 2012. The company's main business covers R&D, production and sales of pharmaceutical injections, solid preparations, and APIs. The company's main products are injectable thymus, injectable somatostatin, injectable bivalirudine, and etibatide injections. Corporate honors: National Torch Program Project Certificate; High-tech Enterprise in Hainan Province; 2002 Honest Tax Paying Enterprise; Famous Trademark of Hainan Province, etc.

Company Profile

Short Name-A双成药业
Symbol-A002693
Company NameHainan Shuangcheng Pharmaceuticals Co., Ltd.
Listing DateAug 8, 2012
Issue Price20.00
Shares Offered30.00M share(s)
FoundedMay 22, 2000
Listed ExchangeSZ Stock Exchange
Legal Representativechengdong wang
General Managerjianming li
Secretaryxiaofeng yu
Accounting FirmShanghui Certified Public Accountants (Special General Partnership)
Securities Representativefen li
Legal CounselBeijing Zhong Lun Law Firm
Employees375
Phone0898-68592978
Office AddressNo. 16, Xing Guo Road, Xiuying District, Haikou City, Hainan Province
Zip Code570314
Registered AddressNo. 16, Xing Guo Road, Xiuying District, Haikou City, Hainan Province
Fax0898-68592978
Emailyuxiaofeng@shuangchengmed.com
Business License460000400004559
BusinessResearch, development, production and sales of injections, capsules, tablets, granules, and APIs; production and sales of chemical products (other than franchises) and general machinery and equipment; consultation and transfer of drug research and development projects; leasing of own housing; transfer and leasing of own patents, unpatented technologies and trademarks.

Company Executives

  • Name
  • Position
  • Salary
  • chengdong wang
  • Chairman,directors
  • --
  • yingpu wang
  • Vice Chairman,directors
  • --
  • jing bai
  • Vice Chairman,directors
  • --
  • jianming li
  • directors,general manager
  • --
  • jianwei li
  • Independent directors
  • 60.00K
  • jianhua xiao
  • Independent directors
  • 60.00K
  • xiaofeng yu
  • Board Secretary,Deputy General Manager
  • 380.00K
  • fen li
  • Securities affairs representative
  • --
  • hongyu wang
  • Chairman of the Supervisory Board,Employee supervisors
  • 203.90K
  • bin fu
  • auditors
  • 227.60K
  • ying chen
  • auditors
  • 120.60K
  • zhong yao
  • Deputy General Manager
  • 833.20K
  • yuan li
  • Deputy General Manager
  • 362.30K
  • haiyan li
  • Deputy General Manager
  • 332.60K
  • shiyin wang
  • Deputy General Manager
  • 367.40K
  • rui wang
  • Deputy General Manager
  • 332.20K
  • yixiang ai
  • Deputy General Manager
  • 362.80K
  • jianlin yuan
  • Deputy General Manager
  • 494.80K
  • xuguang wang
  • Chief Financial Officer
  • 380.00K
  • qi yang
  • Head of Audit Department
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg